|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/155 | (2013.01) |
| A61K 31/155 | (2006.01) | ||
| A61K 31/522 | (2006.01) | ||
| A61K 31/522 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/00 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/12 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 3/08 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/04 | (2018.01) | ||
| A61P 9/06 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 47/183 | (2013.01) |
| (11) | Number of the document | 2482812 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10760351.6 |
| Date of filing the European patent application | 2010-10-01 | |
| (97) | Date of publication of the European application | 2012-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/064691 |
| Date | 2010-10-01 |
| (87) | Number | WO 2011/039367 |
| Date | 2011-04-07 |
| (30) | Number | Date | Country code |
| 09172117 | 2009-10-02 | EP |
| (72) |
MEINICKE, Thomas , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING BI-1356 AND METFORMIN |
| PHARMACEUTICAL COMPOSITIONS COMPRISING BI-1356 AND METFORMIN |